Life sciences

Navigating Digital Deals in Life Sciences Part 5 | Deal Structure, Terms and Series Conclusions

Welcome to the fifth and final episode in our podcast series “Digital Deals in Life Sciences – What Makes Them Different?" Transactions...

Navigating Digital Deals in Life Sciences Part 5 | Deal Structure, Terms and Series Conclusions
by Philip Whitchelo

Welcome to the fifth and final episode in our podcast series “Digital Deals in Life Sciences – What Makes Them Different?" Transactions...

Learn more ->
Navigating Digital Deals in Life Sciences Part 4 | Due Diligence

Welcome to the fourth of five episodes in our podcast series “Digital Deals in Life Sciences – What Makes Them Different?" Transactions...

Navigating Digital Deals in Life Sciences Part 4 | Due Diligence
by Philip Whitchelo

Welcome to the fourth of five episodes in our podcast series “Digital Deals in Life Sciences – What Makes Them Different?" Transactions...

Learn more ->
Navigating Digital Deals in Life Sciences Part 3 | Defining & Valuing the Asset

Welcome to the third of five episodes in our podcast series “Digital Deals in Life Sciences – What Makes Them Different?" Transactions...

Navigating Digital Deals in Life Sciences Part 3 | Defining & Valuing the Asset
by Philip Whitchelo

Welcome to the third of five episodes in our podcast series “Digital Deals in Life Sciences – What Makes Them Different?" Transactions...

Learn more ->
Navigating Digital Deals in Life Sciences Part 2 | Information Governance

Welcome to the second of five episodes in our podcast series “Digital Deals in Life Sciences – What Makes Them Different?" Transactions...

Navigating Digital Deals in Life Sciences Part 2 | Information Governance
by Philip Whitchelo

Welcome to the second of five episodes in our podcast series “Digital Deals in Life Sciences – What Makes Them Different?" Transactions...

Learn more ->
Navigating Digital Deals in Life Sciences Part 1 | Corporate Culture

Welcome to the first of five episodes in our podcast series “Digital Deals in Life Sciences – What Makes Them Different?" Transactions...

Navigating Digital Deals in Life Sciences Part 1 | Corporate Culture
by Philip Whitchelo

Welcome to the first of five episodes in our podcast series “Digital Deals in Life Sciences – What Makes Them Different?" Transactions...

Learn more ->
Commercial real estate spotlight: life sciences

“Two roads diverged in a wood and I – I took the one less traveled by, and that has made all the difference.”1 Following on from my...

Commercial real estate spotlight: life sciences
by Harry Iles
Drug manufacturing laboratory equipment

“Two roads diverged in a wood and I – I took the one less traveled by, and that has made all the difference.”1 Following on from my...

Learn more ->
Webinar: How to maximise value & avoid failure during life sciences dealmaking

During this webinar, a fantastic expert panel of life sciences dealmaking veterans from AstraZeneca and Merck, with 100 years' collective...

Webinar: How to maximise value & avoid failure during life sciences dealmaking
by Philip Whitchelo
Pills spilling out of a bottle

During this webinar, a fantastic expert panel of life sciences dealmaking veterans from AstraZeneca and Merck, with 100 years' collective...

Learn more ->